ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TVTX Travere Therapeutics Inc

7.10
-0.23 (-3.14%)
19 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Travere Therapeutics Inc NASDAQ:TVTX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.23 -3.14% 7.10 6.30 7.83 7.31 6.96 7.29 976,340 01:00:00

Travere Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results

08/02/2024 9:30pm

GlobeNewswire Inc.


Travere Therapeutics (NASDAQ:TVTX)
Historical Stock Chart


From Dec 2023 to Jun 2024

Click Here for more Travere Therapeutics Charts.

Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report fourth quarter and full year 2023 financial results on Thursday, February 15, 2024, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.

The webcast and dial-in information can be accessed on the Investor page of Travere’s website at ir.travere.com/events-presentations. Following the live webcast, an archived version of the call will be available for 30 days on the Company’s website.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.

Investors:888-969-7879ir@travere.comMedia:888-969-7879mediarelations@travere.com

1 Year Travere Therapeutics Chart

1 Year Travere Therapeutics Chart

1 Month Travere Therapeutics Chart

1 Month Travere Therapeutics Chart

Your Recent History

Delayed Upgrade Clock